Literature DB >> 8384087

Letter in response to paper by Abratt et al., Cancer Chemother Pharmacol (1992) 30: 495.

S Senan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384087     DOI: 10.1007/bf00685043

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  16 in total

1.  Carbogen and nicotinamide: expectations too high?

Authors:  J M Brown
Journal:  Radiother Oncol       Date:  1992-06       Impact factor: 6.280

2.  Additive effects of cisplatin and radiation in human tumor cells under oxic conditions.

Authors:  M Flentje; M Eble; U Haner; S Trinh; M Wannenmacher
Journal:  Radiother Oncol       Date:  1992-05       Impact factor: 6.280

Review 3.  The effect of therapy on tumour vascular function.

Authors:  D J Chaplin
Journal:  Int J Radiat Biol       Date:  1991 Jul-Aug       Impact factor: 2.694

4.  The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo.

Authors:  M R Horsman; P J Wood; D J Chaplin; J M Brown; J Overgaard
Journal:  Radiother Oncol       Date:  1990-05       Impact factor: 6.280

5.  Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/St tumor and normal tissues of the C3H/KM mouse.

Authors:  M Tanabe; D Godat; R F Kallman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-10       Impact factor: 7.038

6.  Reoxygenation in the RIF-1 tumor after chemotherapy.

Authors:  M J Dorie; R F Kallman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

Review 7.  Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data.

Authors:  L Dewit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-03       Impact factor: 7.038

8.  Concurrent radiation and weekly cisplatin for non-small-cell lung cancer--a phase I/II study.

Authors:  R P Abratt; P A Willcox; D G Salton
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  The effect of cisplatin on the repair of radiation damage in RIF1 mouse tumours in vivo.

Authors:  A C Begg; S Bohlken; H Bartelink
Journal:  Radiother Oncol       Date:  1989-05       Impact factor: 6.280

10.  Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation.

Authors:  H Bartelink; R F Kallman; D Rapacchietta; G A Hart
Journal:  Radiother Oncol       Date:  1986-05       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.